Nutex Health Files 8-K Current Report
Ticker: NUTX · Form: 8-K · Filed: Jul 25, 2024 · CIK: 1479681
Sentiment: neutral
Topics: 8-K, SEC filing, disclosure
Related Tickers: NUTX
TL;DR
NUTX filed an 8-K on 7/25 for an event on 7/24. Standard disclosure.
AI Summary
Nutex Health, Inc. filed an 8-K on July 25, 2024, reporting an event on July 24, 2024. The filing is a current report under Section 13 or 15(d) of the Securities Exchange Act of 1934. The company, formerly known as Clinigence Holdings, Inc. and iGambit, Inc., is incorporated in Delaware and headquartered in Houston, Texas.
Why It Matters
This filing indicates a routine update or event disclosure by Nutex Health, Inc. to the SEC, which is important for investors to stay informed about the company's operational status and any material developments.
Risk Assessment
Risk Level: low — This filing is a standard 8-K current report, which typically contains routine disclosures and does not inherently signal significant new risks.
Key Players & Entities
- Nutex Health, Inc. (company) — Registrant
- Clinigence Holdings, Inc. (company) — Former company name
- iGambit, Inc. (company) — Former company name
- July 24, 2024 (date) — Date of earliest event reported
- July 25, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for Nutex Health, Inc.?
The filing is a current report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating an event occurred on July 24, 2024.
When was the earliest event reported in this filing?
The earliest event reported was on July 24, 2024.
What are the former names of Nutex Health, Inc. mentioned in the filing?
The filing states that Nutex Health, Inc. was formerly known as Clinigence Holdings, Inc. and iGambit, Inc.
In which state is Nutex Health, Inc. incorporated?
Nutex Health, Inc. is incorporated in Delaware.
What is the principal executive office address for Nutex Health, Inc.?
The address of the principal executive offices is 6030 S. Rice Ave, Suite C, Houston, Texas 77081.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-07-25 17:21:17
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 NUTX The NASDAQ Stock Market LLC
- $1.00 — Company's common stock had traded above $1.00 per share and, accordingly, the Staff o
Filing Documents
- nutx_8k-072524.htm (8-K) — 22KB
- 0001079973-24-001100.txt ( ) — 217KB
- nutx-20240724.xsd (EX-101.SCH) — 3KB
- nutx-20240724_def.xml (EX-101.DEF) — 26KB
- nutx-20240724_lab.xml (EX-101.LAB) — 33KB
- nutx-20240724_pre.xml (EX-101.PRE) — 22KB
- nutx_8k-072524_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On July 24, 2024, Nutex Health Inc. (the "Company") received written notice (the "Compliance Notice") from The Nasdaq Stock Market LLC ("Nasdaq") informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), as required by the Hearing Panel's June 14, 2024 decision, which was previously disclosed in the Company's Current Report on Form 8-K filed on June 18, 2024. Nasdaq notified the Company in the Compliance Notice that, from July 3, 2024, the date of the Company's 1:10 reverse stock split, to July 23, 2024, the closing bid price of the Company's common stock had traded above $1.00 per share and, accordingly, the Staff of Nasdaq determined that the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2). Accordingly, the Hearing Panel determined to continue the listing of the Company's common stock on The Nasdaq Stock Market and closed this matter.
Financial Statements and Exhibits
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description of Exhibit 104 Cover Page Interactive Data File - the cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized. Dated: July 25, 2024 NUTEX HEALTH INC. By: /s/ Jon C. Bates Jon C. Bates Chief Financial Officer